↓ Skip to main content

Dove Medical Press

Article Metrics

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

Overview of attention for article published in Neuropsychiatric Disease and Treatment, June 2020
Altmetric Badge

Mentioned by

facebook
1 Facebook page
Title
<p>Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies</p>
Published in
Neuropsychiatric Disease and Treatment, June 2020
DOI 10.2147/ndt.s242084
Authors

Sharon B. Wigal, Tim Wigal, Mary Hobart, Jessica J Madera, Ross A Baker, Eva Kohegyi, Anthony McKinney, Timothy E Wilens

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2020.
All research outputs
#13,927,585
of 15,791,593 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,032
of 2,564 outputs
Outputs of similar age
#238,824
of 290,858 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 3 outputs
Altmetric has tracked 15,791,593 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,564 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,858 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.